Xbrane Biopharma AB(出版) - 收益表 (TTM)

Xbrane Biopharma AB(出版)
收益表 (TTM)

Xbrane Biopharma AB(出版)收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
收入 5 8 11 15 32 43 58 112 144 189 239 191 192 149 148 227 266 260 152 76
改變 (%) 50.00 40.26 44.70 105.36 36.31 32.82 94.58 28.76 31.03 26.21 -20.01 0.48 -22.25 -0.73 53.46 16.94 -2.28 -41.33 -49.82
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 47 86 141 203 162 109 76 18 54 67 60 63 33
改變 (%) 84.50 63.69 44.54 -20.57 -32.66 -29.95 -76.08 195.03 24.90 -10.51 4.51 -47.42
佔收入的百分比 41.55 59.54 74.38 85.18 84.58 56.68 51.07 12.31 23.66 25.27 23.14 41.23 43.19
營業毛利 5 8 11 15 32 43 58 66 58 48 35 29 83 73 130 174 199 200 90 43
改變 (%) 50.00 40.26 44.70 105.36 36.31 32.82 13.74 -10.86 -17.03 -26.98 -16.77 182.20 -12.18 77.91 33.59 14.47 0.50 -55.14 -51.50
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 58.45 40.46 25.62 14.82 15.42 43.32 48.93 87.69 76.34 74.73 76.86 58.77 56.81
銷售、一般及行政費用 26 32 31 31 29 27 32 36 41 43 40 39 37 39 41 41 49 47 44 40
改變 (%) 19.91 -0.53 -0.22 -8.04 -7.67 18.58 12.91 14.66 4.11 -5.83 -2.04 -4.55 4.27 4.55 -0.47 19.91 -3.87 -6.40 -7.79
佔收入的百分比 517.11 413.37 293.16 202.15 90.52 61.31 54.74 31.76 28.28 22.47 16.77 20.53 19.51 26.16 27.55 17.87 18.32 18.03 28.76 52.86
研發 200 189 161 151 154 169 200 222 256 286 306 324 296 222 162 109 227 229 118 105
改變 (%) -5.31 -15.14 -5.86 2.00 9.57 18.14 11.01 15.53 11.84 6.79 5.95 -8.62 -24.91 -27.12 -32.90 108.38 0.90 -48.44 -10.92
佔收入的百分比 3,927.29 2,479.07 1,499.85 975.77 484.63 389.57 346.50 197.68 177.36 151.39 128.09 169.65 154.28 149.01 109.40 47.84 85.24 88.02 77.36 137.33
營運支出 227 225 187 173 166 174 210 285 369 459 535 510 430 327 230 209 367 363 172 133
改變 (%) -0.96 -16.67 -7.46 -3.89 4.43 20.97 35.50 29.46 24.44 16.66 -4.80 -15.70 -23.91 -29.53 -9.32 75.68 -1.16 -52.51 -22.61
佔收入的百分比 4,455.21 2,941.69 1,747.74 1,117.74 523.08 400.72 364.94 254.13 255.51 242.67 224.29 266.94 223.96 219.19 155.60 91.94 138.12 139.71 113.08 174.40
營業收入 -222 -217 -176 -158 -135 -130 -153 -173 -224 -270 -297 -319 -238 -178 -82 18 -101 -103 -20 -57
改變 (%) -2.13 -18.67 -10.62 -14.63 -3.11 17.02 13.20 29.91 20.21 9.96 7.44 -25.39 -25.24 -53.69 -122.24 -653.24 1.77 -80.67 185.41
佔收入的百分比 -4,355.21 -2,841.69 -1,647.74 -1,017.74 -423.08 -300.72 -264.94 -154.13 -155.51 -142.67 -124.29 -166.94 -123.96 -119.19 -55.60 8.06 -38.12 -39.71 -13.08 -74.40
利息花費 -1 -2 -3 -4 -3 -3 -3 -2 -4 -1 -19 -29 -33 -46 -31 -28 -31 -24 -12 -6
改變 (%) 42.78 33.20 33.46 -2.67 -18.60 -7.32 -5.57 52.56 -84.49 3,106.41 57.03 13.16 39.66 -33.31 -8.90 10.02 -21.10 -50.28 -51.72
佔收入的百分比 -27.23 -25.92 -24.61 -22.70 -10.76 -6.42 -4.48 -2.18 -2.58 -0.31 -7.75 -15.21 -17.13 -30.77 -20.67 -12.27 -11.55 -9.32 -7.90 -7.60
淨利 -231 -219 -188 -173 -148 -144 -173 -195 -252 -291 -388 -427 -407 -371 -266 -161 79 101 127 106
改變 (%) -5.31 -13.97 -8.04 -14.66 -2.43 19.59 12.91 29.38 15.61 33.22 10.05 -4.80 -8.88 -28.16 -39.66 -149.45 26.54 26.58 -16.69
佔收入的百分比 -4,542.83 -2,867.82 -1,759.04 -1,117.91 -464.56 -332.54 -299.41 -173.74 -174.58 -154.04 -162.60 -223.70 -211.94 -248.39 -179.76 -70.69 29.89 38.71 83.52 138.65

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
SE:XBRANE SEK10.60
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista